Abstract:The reads obtained from 10× genomic platform of traumatic epilepsy and hereditary epilepsy were 39.56 M and 30.08 M. The Q30 of RNA reads over 91.6%. After filtering, 7479 traumatic epilepsy and 9357 hereditary epilepsy cells were left for further study. Over 96.4% of the reads are mapped to GRCh38/GRCm38. The cells were differentially distributed in two groups, with higher oligodendrocytes (6522 vs. 2532) and astrocytes (133 vs. 52), lower microglia (2242 vs. 3811) and neurons (3 vs. 203) were observed in hereditary epilepsy than traumatic epilepsy. The DEGs in four cell clusters were identified, with 25 in oligodendrocytes (13 upregulated and 12 downregulated), 87 in microglia (42 upregulated and 45 downregulated), 222 in astrocytes (115 upregulated and 107 downregulated), and 393 in neurons (305 upregulated and 88 downregulated). MTND1P23 (downregulated), XIST (downregulated), and RPS4Y1 (upregulated) were commonly expressed in four cell clusters. The DEGs in microglia and astrocytes were enriched in IL‐17 signaling pathway. Our study explored the cell grouping between traumatic and hereditary epilepsy, and the transcriptome in different cells for the first time. Inflammatory and immune functions might be the main approaches in traumatic temporal lobe epilepsy of neurons. Background Single‐cell RNA sequencing analysis has been usually conducted on post‐traumatic epilepsy (PET) and hereditary epilepsy (HE) patients; however, the transcriptome of patients with traumatic temporal lobe epilepsy has rarely been studied. Materials and Methods Hippocampus tissues isolated from one patient with PTE and one patient with HE were used in the present study. Single cell isolates were prepared and captured using a 10× Genomics Chromium Single‐Cell 3′ kit (V3) according to the manufacturer's instructions. The libraries were sequenced on an Illumina NovaSeq 6000 sequencing system. Raw data were processed, and the cells were filtered and classified using the Seurat R package. Uniform Manifold Approximation and Projection was used for visualization. Differentially expressed genes (DEGs) were identified based on a p‐value ≤0.01 and log fold change (FC) ≥0.25. Gene Ontology (GO, http://geneontology.org/) and KEGG (Kyoto Encyclopedia of Genes and Genomes, www.genome.jp/kegg) analyses were performed on the DEGs for enrichment analysis. Results The reads obtained from the 10× genomic platform for PTE and HE were 39.56 M and 30.08 M, respectively. The Q30 score of the RNA reads was >91.6%. After filtering, 7479 PTE cells and 9357 HE cells remained for further study. More than 96.4% of the reads were mapped to GRCh38/GRCm38. The cells were differentially distributed in two groups, with higher numbers of oligodendrocytes (6522 vs. 2532) and astrocytes (133 vs. 52), and lower numbers of microglial cells (2242 vs. 3811), and neurons (3 vs. 203) present in the HE group than in the PTE group. The DEGs in four cell clusters were identified, with 25 being in oligodendrocytes (13 upregulated and 12 downregulated), 87 in microglia cells (42 upregulated and 45 downregulated), 222 in astrocytes (115 upregulated and 107 downregulated), and 393 in neurons (305 upregulated and 88 downregulated). The genes MTND1P23 (downregulated), XIST (downregulated), and RPS4Y1 (upregulated) were commonly expressed in all four cell clusters. The DEGs in microglial cells and astrocytes were enriched in the IL‐17 signaling pathway. Conclusion Our study explored differences in cells found in a patient with PE compared to a patient with HE, and the transcriptome in the different cells was analyzed for the first time. Studying inflammatory and immune functions might be the best approach for investigating traumatic temporal lobe epilepsy in neurons.

Additional File 3 of High-resolution Transcriptomics Informs Glial Pathology in Human Temporal Lobe Epilepsy

High-resolution Transcriptomics Informs Glial Pathology in Human Temporal Lobe Epilepsy

RNA Sequencing Analysis of Cortex and Hippocampus in a Kainic Acid Rat Model of Temporal Lobe Epilepsy to Identify Mechanisms and Therapeutic Targets Related to Inflammation, Immunity and Cognition.

Cell type-specific isolation and transcriptomic profiling informs glial pathology in human temporal lobe epilepsy

Single-cell, single-nucleus and xenium-based spatial transcriptomics analyses reveal inflammatory activation and altered cell interactions in the hippocampus in mice with temporal lobe epilepsy

Supplementary Material For: High-Throughput Data of Circular RNA Profiles in Human Temporal Cortex Tissue Reveals Novel Insights into Temporal Lobe Epilepsy

Bioinformatic Analysis Identifies Key Transcriptome Signatures in Temporal Lobe Epilepsy

Integrated Analysis of Expression Profile and Potential Pathogenic Mechanism of Temporal Lobe Epilepsy With Hippocampal Sclerosis

Molecular mechanism analyses of post‐traumatic epilepsy and hereditary epilepsy based on 10× single‐cell transcriptome sequencing technology

Additional File 1: of RNAseq Analysis of Hippocampal Microglia after Kainic Acid-Induced Seizures

Profiling Analysis of Circular RNA and mRNA in Human Temporal Lobe Epilepsy with Hippocampal Sclerosis ILAE Type 1

Additional File 5 of Spatially Resolved Transcriptomics Reveals Genes Associated with the Vulnerability of Middle Temporal Gyrus in Alzheimer’s Disease

Differences in Whole-Brain Metabolism Are Associated with the Expression of Genes Related to Neurovascular Unit Integrity and Synaptic Plasticity in Temporal Lobe Epilepsy.

High-Throughput Data of Circular RNA Profiles in Human Temporal Cortex Tissue Reveals Novel Insights into Temporal Lobe Epilepsy.

Gene and Protein Alterations in the Hippocampus of Rats with Temporal Lobe Epilepsy

Single-nucleus transcriptome atlas of orbitofrontal cortex in amyotrophic lateral sclerosis with a deep learning-based decoding of alternative polyadenylation mechanisms

Compartment-specific small non-coding RNA changes and nucleolar defects in human mesial temporal lobe epilepsy

Additional File 4: of Molecular and Clinical Characterization of PTPN2 Expression from RNA-seq Data of 996 Brain Gliomas

GluN3 subunit expression correlates with increased vulnerability of hippocampus and entorhinal cortex to neurodegeneration in a model of temporal lobe epilepsy

iTRAQ-Based Proteomic Analysis of Dentate Gyrus in Temporal Lobe Epilepsy With Hippocampal Sclerosis

Combined transcriptomics and proteomics forecast analysis for potential biomarker in the acute phase of temporal lobe epilepsy